MedPath

Development of a Culturally Tailored Resilience-building Intervention for Chinese American's Advance Care Planning Discussions

Not Applicable
Recruiting
Conditions
Advance Care Planning
Heart Diseases
Neoplasms
Registration Number
NCT06247215
Lead Sponsor
University of Illinois at Chicago
Brief Summary

Less than 15% of Chinese Americans complete advance directives. That is less than half of the 37% completion rate in the US general population. This disparity in the use of advance care planning between White Americans and Chinese Americans may extend to disparities in end-of-life care. To address such disparities in end-of-life care, we will develop and assess the acceptability of a culturally tailored resilience-building intervention to help Chinese Americans with cancer or heart disease and their family caregivers engage in advance care planning discussions.

Detailed Description

The overall objective of this cross-sectional pilot study is to develop a culturally tailored resilience-building intervention for Chinese Americans with cancer or heart disease in Chicago. A qualitative analysis of semi-structured interviews will be conducted to identify how religious leaders addressed death-related topics with Chinese Americans with cancer or heart disease in Chicago. In addition, a usability test of a resilience-building intervention prototype will be conducted to to understand the feasibility and acceptability among 18 pairs of Chinese Americans and their family caregivers (9 pairs with cancer and 9 pairs with heart disease).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
36
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
AcceptabilityImmediately at the end of the usability testing

The Theoretical Framework of Acceptability, which ranges from 1 to 5, will be used to assess acceptability. A higher score indicates higher acceptability.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Illinois Chicago

🇺🇸

Chicago, Illinois, United States

University of Illinois Chicago
🇺🇸Chicago, Illinois, United States
Li-Ting H. Longcoy
Contact
312-996-3024
liting@uic.edu
© Copyright 2025. All Rights Reserved by MedPath